Search results
Results from the WOW.Com Content Network
Cannabidiol (CBD) is a phytocannabinoid, ... Side effects of CBD are dose related. [50] Epidiolex documentation lists sleepiness, insomnia and poor quality sleep, ...
Cannabichromene (CBC), also called cannabichrome, cannanbichromene, pentylcannabichromene or cannabinochromene, [1] exhibits anti-inflammatory properties in vitro, which may, theoretically, contribute to cannabis analgesic effects. [2] It is a phytocannabinoid, one of the hundreds of cannabinoids found in the Cannabis plant. [3]
CBD is hydroxylated by P450 liver enzymes into 7-OH-CBD. Its metabolites are products of primarily CYP2C19 and CYP3A4 activity, with potential activity of CYP1A1, CYP1A2, CYP2C9, and CYP2D6. [69] Similar to delta-9-THC, a majority of CBD is excreted in feces and some in the urine. [57] The terminal half-life is approximately 18–32 hours. [70]
This is sponsored content. Us Weekly is not endorsing the websites or products set forth below. The use of THC in any capacity may lead to health concerns and users should consult medical ...
From Our Partners. For premium support please call: 800-290-4726 more ways to reach us
Such effects may include analgesia, decreased inflammation, decreased spasticity, and anti-seizure effects. [26] Cannabis edibles with CBD can decrease symptoms of psychosis and anxiety. [25] Edible oils, tinctures, pills, and gummies have been prescribed to people with cancer to potentially improve poor appetite, pain, or weight loss. [27]
H4CBD (hydrogenated CBD, tetrahydrocannabidiol) is a cannabinoid that was first synthesized by Alexander R. Todd in 1940 derived from the catalytic hydrogenation of cannabidiol. [ 1 ] H2-CBD and 8,9-dihydrocannabidiol have also been referred to as "hydrogenated CBD", which may cause confusion.
Dose-dependent anxiolytic effects, [13] with anxiogenic effects at high doses; Appetite stimulation [13] [14] Anti-nausea [13] [14] In combination with CBD, potential efficacy in treatment of spasticity, neuropathic pain and muscle spasticity (see Sativex: THC-containing therapeutic approved in Europe as treatment for Multiple Sclerosis)